✦ LIBER ✦

S30-7 PROSPECTIVE STUDY OF WARFARIN DOSAGE REQUIREMENTS BASED ON CYP2C9 AND VKORC1 GENOTYPES

✍ Scribed by Ming-Shien Wen; M.T. Michael Lee; Jin-Jer Chen; Hui-Ping Chuang; Liang-Suei Lu; Chien-Hsiun Chen; Tsong-Hai Lee; Chi-Tai Kuo; Feng-Mei Sun; Yeu-Jhy Chang; Pei-Liang Kuan; Ying-Fu Chen; Min-Ji Charng; Chin-Ying Ray; Jer-Yuan Wu; Yuan-Tsong Chen

Book ID: 117353257
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 58 KB
Volume: 122
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(08)70486-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Study of Warfarin Dosage Req

Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes

✍ Wen, M-S; Lee, MTM; Chen, J-J; Chuang, H-P; Lu, L-S; Chen, C-H; Lee, T-H; Kuo, C 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 232 KB

VKORC1 and CYP2C9 genotype and patient c

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

✍ Biss, T. T.; Avery, P. J.; Brandao, L. R.; Chalmers, E. A.; Williams, M. D.; Gra 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 302 KB

SYBR Green-based real-time PCR assay for

SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement

✍ Huang, Sheng-Wen; Li, Qiang; Zhu, Sheng-Yuan; Li, Liang; Xiong, Fu; Jia, Yan-Kai 📂 Article 📅 2009 🏛 Walter de Gruyter GmbH & Co. KG 🌐 English ⚖ 153 KB

A PK–PD Model for Predicting the Impact

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy

✍ Hamberg, A-K; Dahl, M-L; Barban, M; Scordo, M G; Wadelius, M; Pengo, V; Padrini, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Influence of CYP2C9 and VKORC1 1173C/T G

Influence of CYP2C9 and VKORC1 1173C/T Genotype on the Risk of Hemorrhagic Complications in African-American and European-American Patients on Warfarin

✍ Limdi, NA; McGwin, G; Goldstein, JA; Beasley, TM; Arnett, DK; Adler, BK; Baird, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB

PCV45 COST-EFFECTIVENESS OF CYP2C9 AND V

PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE: THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM

✍ R. Teschemaker; W. Lawrence; A.K. Wutoh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB